124 related articles for article (PubMed ID: 2083133)
1. [Adrenal medullary graft induces recovery of the host nigrostriatal dopaminergic system in MPTP-induced mouse model of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Dec; 42(12):1173-8. PubMed ID: 2083133
[TBL] [Abstract][Full Text] [Related]
2. [Cografts of adrenal medulla and peripheral nerve in a mouse model of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten D
No Shinkei Geka; 1991 Sep; 19(9):811-5. PubMed ID: 1944788
[TBL] [Abstract][Full Text] [Related]
3. The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft.
Date I; Felten SY; Felten DL
Brain Res; 1991 Apr; 545(1-2):191-8. PubMed ID: 1860045
[TBL] [Abstract][Full Text] [Related]
4. [Cografting technique in the treatment of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten D
No Shinkei Geka; 1991 Oct; 19(10):919-24. PubMed ID: 1944775
[TBL] [Abstract][Full Text] [Related]
5. Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice.
Date I; Felten SY; Felten DL
Brain Res; 1990 Dec; 537(1-2):33-9. PubMed ID: 1982243
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cografts of pretransected peripheral nerve with adrenal medulla in animal models of Parkinson's disease.
Date I; Yoshimoto Y; Gohda Y; Furuta T; Asari S; Ohmoto T
Neurosurgery; 1993 Oct; 33(4):685-90. PubMed ID: 7901795
[TBL] [Abstract][Full Text] [Related]
7. Bilateral recovery of striatal dopamine after unilateral adrenal grafting into the striatum of the 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-treated mouse.
Bohn MC; Kanuicki M
J Neurosci Res; 1990 Mar; 25(3):281-6. PubMed ID: 1969970
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease.
Date I; Miyoshi Y; Imaoka T; Furuta T; Asari S; Ohmoto T
Neurosci Res; 1994 Sep; 20(3):213-21. PubMed ID: 7838422
[TBL] [Abstract][Full Text] [Related]
9. Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.
Date I; Ohmoto T
Exp Neurol; 1996 Feb; 137(2):333-44. PubMed ID: 8635549
[TBL] [Abstract][Full Text] [Related]
10. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
Otto D; Unsicker K
Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
[TBL] [Abstract][Full Text] [Related]
11. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
12. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice.
Date I; Felten SY; Olschowka JA; Felten DL
Exp Neurol; 1990 Mar; 107(3):197-207. PubMed ID: 2307201
[TBL] [Abstract][Full Text] [Related]
13. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.
Bohn MC; Cupit L; Marciano F; Gash DM
Science; 1987 Aug; 237(4817):913-6. PubMed ID: 2887034
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
15. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.
Date I; Shingo T; Ohmoto T; Emerich DF
Exp Neurol; 1997 Sep; 147(1):10-7. PubMed ID: 9294398
[TBL] [Abstract][Full Text] [Related]
16. Effect of host age upon the degree of nigrostriatal dopaminergic system recovery following cografts of adrenal medulla and pretransected peripheral nerve.
Date I; Yoshimoto Y; Imaoka T; Miyoshi Y; Furuta T; Asari S; Ohmoto T
Brain Res; 1994 Feb; 637(1-2):50-6. PubMed ID: 7910105
[TBL] [Abstract][Full Text] [Related]
17. Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging.
Date I; Yoshimoto Y; Imaoka T; Miyoshi Y; Gohda Y; Furuta T; Asari S; Ohmoto T
Brain Res; 1993 Sep; 621(1):150-4. PubMed ID: 8106113
[TBL] [Abstract][Full Text] [Related]
18. Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla.
Bohn MC; Marciano F; Cupit L; Gash DM
Prog Brain Res; 1988; 78():535-42. PubMed ID: 3266803
[No Abstract] [Full Text] [Related]
19. Adrenal medulla and Parkinson's disease.
Stoddard SL; Merkel GJ; Cook JA; Zinsmeister AR; Carmichael SW
Microsc Res Tech; 1994 Oct; 29(2):151-4. PubMed ID: 7812036
[TBL] [Abstract][Full Text] [Related]
20. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
